Tandem Diabetes Care, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Tandem Diabetes Care, Inc. (TNDM) holds an ST Score of 53.2 out of 100 (B-), with its strongest factor being Valuation (B+) and its weakest Financial Strength (D+). Analysts rate TNDM Buy across 39 ratings with a $30.17 average price target (+0.8% vs the current $16.87).
- Strongest
- ValuationB+
- Weakest
- Financial StrengthD+
All factor grades
- ValuationB+
- GrowthB+
- ForecastB+
- ProfitabilityB
- SentimentC+
- MomentumC
- Financial StrengthD+
- Piotroski3/9
Contact
TNDM stock: frequently asked questions
What is TNDM's ST Score?
Tandem Diabetes Care, Inc. (TNDM) has an ST Score of 53.2 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is TNDM a buy, sell, or hold?
Wall Street's consensus rating on TNDM is Buy based on 39 analyst ratings. Our own ST Score grades it B- (53.2/100). This is data, not investment advice — always do your own research.
What is TNDM's valuation grade?
Tandem Diabetes Care, Inc. (TNDM) earns a valuation grade of B+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is TNDM's growth grade?
Tandem Diabetes Care, Inc. (TNDM) earns a growth grade of B+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is TNDM's profitability grade?
Tandem Diabetes Care, Inc. (TNDM) earns a profitability grade of B, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is TNDM's financial strength grade?
Tandem Diabetes Care, Inc. (TNDM) earns a financial strength grade of D+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for TNDM?
The average analyst price target for Tandem Diabetes Care, Inc. (TNDM) is $30.17 from 39 analysts, which is +0.8% versus the recent price of $16.87.
What is TNDM's Piotroski score?
Tandem Diabetes Care, Inc. (TNDM) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.